Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Treatment of HCV infection by targeting microRNA.

Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR.

N Engl J Med. 2013 May 2;368(18):1685-94. doi: 10.1056/NEJMoa1209026. Epub 2013 Mar 27.

2.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
3.

Targeting microRNA-122: walking on cutting edge of hepatitis C virus infection therapy.

Motavaf M, Safari S, Alavian SM.

Acta Virol. 2014;58(4):301-8. Review.

PMID:
25518710
4.

Roadmap of miR-122-related clinical application from bench to bedside.

Qiu Z, Dai Y.

Expert Opin Investig Drugs. 2014 Mar;23(3):347-55. doi: 10.1517/13543784.2014.867327. Epub 2013 Dec 20. Review.

PMID:
24354366
5.

MicroRNA-targeting therapeutics for hepatitis C.

Baek J, Kang S, Min H.

Arch Pharm Res. 2014 Mar;37(3):299-305. doi: 10.1007/s12272-013-0318-9. Epub 2014 Jan 3. Review.

PMID:
24385319
6.

Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids.

Machlin ES, Sarnow P, Sagan SM.

Curr Gene Ther. 2012 Aug;12(4):301-6. Review.

PMID:
22856605
7.

Engineered microRNA therapeutics.

Gibson NW.

J R Coll Physicians Edinb. 2014;44(3):196-200. doi: 10.4997/JRCPE.2014.302. Review.

PMID:
25318394
8.

[Overview of locked nucleic acid(LNA)- SPC3649 and its application in HCV treatment].

Zhang L, Tan WJ.

Bing Du Xue Bao. 2011 Nov;27(6):614-8. Review. Chinese. No abstract available.

PMID:
22263277

Supplemental Content

Support Center